Search research articles
Contact Us
Filters
Showing results (311-320 of 356) with videos related to
Page
of 36
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 22, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma
Sara Taranto, Jessica Faletti, Mariangela Tamburello, et al.
Molecular Pharmaceutics
|
September 30, 2017
Original Multivalent Gold(III) and Dual Gold(III)-Copper(II) Conjugated Phosphorus Dendrimers as Potent Antitumoral and Antimicrobial Agents
Serge M Mignani, Nabil El Brahmi, Saïd El Kazzouli, et al.
Circulation. Cardiovascular Imaging
|
April 5, 2019
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease
Antonia Camporeale, Maurizio Pieroni, Federico Pieruzzi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists
S Mignani, G A Bohme, A Boireau, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2014
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
Cédric Lecoutey, Damien Hedou, Thomas Freret, et al.
Sleep Medicine
|
February 20, 2021
The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units
Giuseppe Loddo, Giusy La Fauci, Luca Vignatelli, et al.
Bioorganic & Medicinal Chemistry
|
September 26, 2000
8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e] pyrazine-4-ones: highly in vivo potent and selective AMPA receptor antagonists
P Jimonet, M Chevé, G A Bohme, et al.
Plos One
|
July 4, 2017
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy
Rocco Liguori, Alex Incensi, Silvia de Pasqua, et al.
Biomacromolecules
|
May 10, 2021
Safe Polycationic Dendrimers as Potent Oral In Vivo Inhibitors of <i>Mycobacterium tuberculosis</i>: A New Therapy to Take Down Tuberculosis
Serge Mignani, Vishwa Deepak Tripathi, Dheerj Soam, et al.
Neurosurgical Focus
|
December 2, 2016
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas
Matteo Zoli, Luisa Sambati, Laura Milanese, et al.
Page
of 36
Search research articles
Search
Showing results (311-320 of 356) with videos related to
Sort By:
Page
of 36
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 22, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma
Sara Taranto, Jessica Faletti, Mariangela Tamburello, et al.
Molecular Pharmaceutics
|
September 30, 2017
Original Multivalent Gold(III) and Dual Gold(III)-Copper(II) Conjugated Phosphorus Dendrimers as Potent Antitumoral and Antimicrobial Agents
Serge M Mignani, Nabil El Brahmi, Saïd El Kazzouli, et al.
Circulation. Cardiovascular Imaging
|
April 5, 2019
Predictors of Clinical Evolution in Prehypertrophic Fabry Disease
Antonia Camporeale, Maurizio Pieroni, Federico Pieruzzi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 31, 2000
8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists
S Mignani, G A Bohme, A Boireau, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2014
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
Cédric Lecoutey, Damien Hedou, Thomas Freret, et al.
Sleep Medicine
|
February 20, 2021
The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units
Giuseppe Loddo, Giusy La Fauci, Luca Vignatelli, et al.
Bioorganic & Medicinal Chemistry
|
September 26, 2000
8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e] pyrazine-4-ones: highly in vivo potent and selective AMPA receptor antagonists
P Jimonet, M Chevé, G A Bohme, et al.
Plos One
|
July 4, 2017
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy
Rocco Liguori, Alex Incensi, Silvia de Pasqua, et al.
Biomacromolecules
|
May 10, 2021
Safe Polycationic Dendrimers as Potent Oral In Vivo Inhibitors of <i>Mycobacterium tuberculosis</i>: A New Therapy to Take Down Tuberculosis
Serge Mignani, Vishwa Deepak Tripathi, Dheerj Soam, et al.
Neurosurgical Focus
|
December 2, 2016
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas
Matteo Zoli, Luisa Sambati, Laura Milanese, et al.
Page
of 36